These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12742671)

  • 1. Modern proteomic strategies in the study of complex neuropsychiatric disorders.
    Rohlff C; Hollis K
    Biol Psychiatry; 2003 May; 53(10):847-53. PubMed ID: 12742671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic approaches to central nervous system disorders.
    Rohlff C; Southan C
    Curr Opin Mol Ther; 2002 Jun; 4(3):251-8. PubMed ID: 12139311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic and Microscopic Strategies towards the Analysis of the Cytoskeletal Networks in Major Neuropsychiatric Disorders.
    Coumans JV; Palanisamy SK; McFarlane J; Moens PD
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in neuropsychiatric disorders.
    Rohlff C
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):93-102. PubMed ID: 11343634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical tools and current challenges in the modern era of neuroepigenomics.
    Maze I; Shen L; Zhang B; Garcia BA; Shao N; Mitchell A; Sun H; Akbarian S; Allis CD; Nestler EJ
    Nat Neurosci; 2014 Nov; 17(11):1476-90. PubMed ID: 25349914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders.
    Vinod KY; Hungund BL
    Life Sci; 2005 Aug; 77(14):1569-83. PubMed ID: 16005471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central nervous system transcriptome of the weakly electric brown ghost knifefish (Apteronotus leptorhynchus): de novo assembly, annotation, and proteomics validation.
    Salisbury JP; Sîrbulescu RF; Moran BM; Auclair JR; Zupanc GK; Agar JN
    BMC Genomics; 2015 Mar; 16(1):166. PubMed ID: 25879418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of kidney and urine proteome databases.
    Yoshida Y; Miyamoto M; Bo X; Yaoita E; Yamamoto T
    Contrib Nephrol; 2008; 160():186-197. PubMed ID: 18401170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic biomarkers for psychiatric disorders: a progress update.
    Martins-de-Souza D; Turck CW
    Biomark Med; 2012 Apr; 6(2):189-92. PubMed ID: 22448792
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the experimental detection of central nervous system-related genes in human brain and cerebrospinal fluid datasets.
    Mueller M; Vizcaíno JA; Jones P; Côté R; Thorneycroft D; Apweiler R; Hermjakob H; Martens L
    Proteomics; 2008 Mar; 8(6):1138-48. PubMed ID: 18283668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Studies of Psychiatric Disorders.
    Guest PC
    Methods Mol Biol; 2018; 1735():59-89. PubMed ID: 29380307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of gel-based and gel-free proteomic data for functional analysis of proteins through Soybean Proteome Database.
    Komatsu S; Wang X; Yin X; Nanjo Y; Ohyanagi H; Sakata K
    J Proteomics; 2017 Jun; 163():52-66. PubMed ID: 28499913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics in molecular medicine: applications in central nervous systems disorders.
    Rohlff C
    Electrophoresis; 2000 Apr; 21(6):1227-34. PubMed ID: 10786895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in neuromembrane proteomics: efforts towards a comprehensive analysis of membrane proteins in the brain.
    Grant KJ; Wu CC
    Brief Funct Genomic Proteomic; 2007 Mar; 6(1):59-69. PubMed ID: 17353200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in blood-related proteomics.
    Thadikkaran L; Siegenthaler MA; Crettaz D; Queloz PA; Schneider P; Tissot JD
    Proteomics; 2005 Aug; 5(12):3019-34. PubMed ID: 16041673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics: state of the art and its application in cardiovascular research.
    Scobioala S; Klocke R; Michel G; Kuhlmann M; Nikol S
    Curr Med Chem; 2004 Dec; 11(24):3203-18. PubMed ID: 15579008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.
    Shen LH; Tseng YC; Liao MH; Fu YK
    J Biomed Biotechnol; 2011; 2011():439397. PubMed ID: 21541178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system receptors in neuropsychiatric disorders.
    Kato G; Ban T
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):207-22. PubMed ID: 6216501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.